61 related articles for article (PubMed ID: 28396035)
21. The Broad Host Range and Genetic Diversity of Mammalian and Avian Astroviruses.
Donato C; Vijaykrishna D
Viruses; 2017 May; 9(5):. PubMed ID: 28489047
[TBL] [Abstract][Full Text] [Related]
22. Signalome-wide assessment of host cell response to hepatitis C virus.
Haqshenas G; Wu J; Simpson KJ; Daly RJ; Netter HJ; Baumert TF; Doerig C
Nat Commun; 2017 May; 8():15158. PubMed ID: 28480889
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of Pb-induced changes and prediction of Pb exposure in microalgae using infrared spectroscopy.
Dao L; Beardall J; Heraud P
Aquat Toxicol; 2017 Jul; 188():33-42. PubMed ID: 28445789
[TBL] [Abstract][Full Text] [Related]
24. The incidence of MRSA infections in the United States: is a more comprehensive tracking system needed?
Kavanagh KT; Abusalem S; Calderon LE
Antimicrob Resist Infect Control; 2017; 6():34. PubMed ID: 28396730
[TBL] [Abstract][Full Text] [Related]
25. Virulence attributes of successful methicillin-resistant
Jiang J-H; Cameron DR; Nethercott C; Aires-de-Sousa M; Peleg AY
Clin Microbiol Rev; 2023 Dec; 36(4):e0014822. PubMed ID: 37982596
[TBL] [Abstract][Full Text] [Related]
26. Vancomycin Resistance in
Li G; Walker MJ; De Oliveira DMP
Microorganisms; 2022 Dec; 11(1):. PubMed ID: 36677316
[No Abstract] [Full Text] [Related]
27. Effect of Antibiotic Exposure on
Pouget C; Chatre C; Lavigne JP; Pantel A; Reynes J; Dunyach-Remy C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675063
[TBL] [Abstract][Full Text] [Related]
28.
McConville TH; Austin ED; Geng W; Shi Q; Balasubramanian D; Kubin CJ; Torres VJ; Uhlemann AC
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0155921. PubMed ID: 34748383
[TBL] [Abstract][Full Text] [Related]
29. Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive
Jin Y; Yu X; Zhang S; Kong X; Chen W; Luo Q; Zheng B; Xiao Y
Front Microbiol; 2020; 11():596942. PubMed ID: 33193280
[TBL] [Abstract][Full Text] [Related]
30. Differential Induction of Type I and III Interferons by
Peignier A; Planet PJ; Parker D
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32690637
[No Abstract] [Full Text] [Related]
31. Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in
Choi S; Moon SM; Park SJ; Lee SC; Jung KH; Sung HS; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041713
[TBL] [Abstract][Full Text] [Related]
32. Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.
Miller LS; Fowler VG; Shukla SK; Rose WE; Proctor RA
FEMS Microbiol Rev; 2020 Jan; 44(1):123-153. PubMed ID: 31841134
[TBL] [Abstract][Full Text] [Related]
33. Interleukin (IL)-1β and IL-10 Host Responses in Patients With Staphylococcus aureus Bacteremia Determined by Antimicrobial Therapy.
Volk CF; Burgdorf S; Edwardson G; Nizet V; Sakoulas G; Rose WE
Clin Infect Dis; 2020 Jun; 70(12):2634-2640. PubMed ID: 31365924
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneous Vancomycin-Intermediate
Dai Y; Gao C; Chen L; Chang W; Yu W; Ma X; Li J
Front Microbiol; 2019; 10():1222. PubMed ID: 31214151
[TBL] [Abstract][Full Text] [Related]
35. Absence of Protein A Expression Is Associated With Higher Capsule Production in Staphylococcal Isolates.
Brignoli T; Manetti AGO; Rosini R; Haag AF; Scarlato V; Bagnoli F; Delany I
Front Microbiol; 2019; 10():863. PubMed ID: 31133995
[No Abstract] [Full Text] [Related]
36. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
Taglialegna A; Varela MC; Rosato RR; Rosato AE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
[TBL] [Abstract][Full Text] [Related]
37. Impact of Staphylococcus aureus regulatory mutations that modulate biofilm formation in the USA300 strain LAC on virulence in a murine bacteremia model.
Rom JS; Atwood DN; Beenken KE; Meeker DG; Loughran AJ; Spencer HJ; Lantz TL; Smeltzer MS
Virulence; 2017 Nov; 8(8):1776-1790. PubMed ID: 28910576
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors.
Cameron DR; Lin YH; Trouillet-Assant S; Tafani V; Kostoulias X; Mouhtouris E; Skinner N; Visvanathan K; Baines SL; Howden B; Monk IR; Laurent F; Stinear TP; Howden BP; Peleg AY
Clin Microbiol Infect; 2017 Oct; 23(10):767-773. PubMed ID: 28396035
[TBL] [Abstract][Full Text] [Related]
39. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
[TBL] [Abstract][Full Text] [Related]
40. VraR Binding to the Promoter Region of
Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
